logo-loader
viewLUFF Enterprises Ltd

Ascent Industries changes name to LUFF Enterprises Ltd and appoints Philip Campbell as CEO

The newly christened company expects to resume trading under Luff Enterprises Ltd and its new ticker symbol 'LUFF' on Monday

Ascent Industries  -- changes name to Luff Enterprises Ltd and appoints Philip Campbel as CEO
The company is mainly focused on the US, where it aims to have a varied portfolio of edible and CBD products

Ascent Industries Corp (CSE:ASNT) (OTCMKTS:PGTMF) announced that it has changed its name to LUFF Enterprises Ltd (CSE:LUFF) and appointed Philip Campbell as the CEO to streamline business operations for the Vancouver-based cannabis company.

The newly christened company said it expects to resume trading under LUFF Enterprises Ltd and its new ticker symbol later on Monday.

In a statement on Friday, the cannabis company said that CEO Campbell would focus on the “reactivation” of the company’s US operations. The company currently holds licenses in Oregon for processing and distribution of cannabis, and in Nevada for cultivation and production, processing and wholesale distribution of cannabis. It also has licenses for the production of hemp-based cannabinoid wellness products.

READ: Ascent Industries announces key CCAA creditors meeting

The company is mainly focused on the US, where it aims to have a varied portfolio of edible and CBD products. In Oregon, Ascent has cannabis and hemp handling licenses and a 7,000 square-foot facility in Portland. The firm has plans to develop and convert the existing facility to a hemp-derived CBD extraction facility.

In Nevada, the firm owns a 37,000 square-foot facility in Las Vegas.

With Cambell now in the driver’s seat, Mark Lotz has stepped down as interim CEO and will continue to serve as CFO and a director until the company’s annual general meeting.

Contact the author Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive

Quick facts: LUFF Enterprises Ltd

Price: 0.015 CAD

CSE:LUFF
Market: CSE
Market Cap: $4.75 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Helix BioPharma extends Moffitt cancer center collaboration to further...

Helix BioPharma Corp (TSX:HBP) (OTCMKTS:HBPCF) CEO Heman Chao tells Proactive the immuno-oncology focused biotech has extended its collaboration with the Florida-based Moffitt Cancer Center for a further year, building on the pair's progress so far. Chao says Helix and Moffitt have already...

22 minutes ago

2 min read